Chemical characterization of non-psychoactive Cannabis sativa L. extracts, in vitro antiproliferative activity and induction of apoptosis in chronic myelogenous leukaemia cancer cells.

Lisa Anceschi, Alessandro Codeluppi, Virginia Brighenti, Riccardo Tassinari, Valentina Taglioli, Lucia Marchetti, Luca Roncati, Andrea Alessandrini, Lorenzo Corsi, Federica Pellati

Journal: Phytotherapy research : PTR 2022;36(2):914-927

PMID: 35107862

Abstract

In this study, extracts from non-psychoactive Cannabis sativa L. varieties were characterized by means of ultra high-performance liquid chromatography coupled with high-resolution mass spectrometry (UHPLC-HRMS) and their antiproliferative activity was assessed in vitro. The human chronic myelogenous leukaemia cell line K562 was chosen to investigate the mechanism of cell death. The effect on the cell cycle and cell death was analysed by flow cytometry. Proteins related to apoptosis were studied by western blotting. Mechanical properties of cells were assessed using the Micropipette Aspiration Technique (MAT). The results indicated that the cannabidiol (CBD)-rich extract inhibited cell proliferation of K562 cell line in a dose-dependent manner and induced apoptosis via caspase 3 and 7 activation. A significant decrease in the mitochondrial membrane potential was detected, together with the release of cytochrome c into the cytosol. The main apoptotic markers were not involved in the mechanism of cell death. The extract was also able to modify the mechanical properties of cells. Thus, this hemp extract and its pure component CBD deserve further investigation for a possible application against myeloproliferative diseases, also in association with other anticancer drugs.

© 2022 The Authors. Phytotherapy Research published by John Wiley & Sons Ltd.

Address: Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.; National Laboratory of Molecular Biology and Stem Cell Bioengineering-Eldor Lab, National Institute of Biostructures and Biosystems (NIBB), Innovation Accelerator, CNR, Bologna, Italy.; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum University of Bologna, Bologna, Italy.; Institute of Pathology, University of Modena and Reggio Emilia, Modena, Italy.; Department of Physics, Informatics and Mathematics, University of Modena and Reggio Emilia, Modena, Italy.; National Research Council (CNR), CNR-Nanoscience Institute-S3, Modena, Italy.; Biostructures and Biosystems National Institute (INBB) Inter-University Consortium, Rome, Italy.; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Biostructures and Biosystems National Institute (INBB) Inter-University Consortium, Rome, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.